233 related articles for article (PubMed ID: 30329047)
1. Ubiquitin specific protease-13 independently regulates parkin ubiquitination and alpha-synuclein clearance in alpha-synucleinopathies.
Liu X; Hebron M; Shi W; Lonskaya I; Moussa CE
Hum Mol Genet; 2019 Feb; 28(4):548-560. PubMed ID: 30329047
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Ubiquitin-Specific Protease-13 Improves Behavioral Performance in Alpha-Synuclein Expressing Mice.
Liu X; Balaraman K; Lynch CC; Hebron M; Shah PK; Hu S; Stevenson M; Wolf C; Moussa C
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897705
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.
Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ
Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin Specific Protease 13 Regulates Tau Accumulation and Clearance in Models of Alzheimer's Disease.
Liu X; Hebron ML; Mulki S; Wang C; Lekah E; Ferrante D; Shi W; Kurd-Misto B; Moussa C
J Alzheimers Dis; 2019; 72(2):425-441. PubMed ID: 31594232
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitination increases parkin activity to promote autophagic α-synuclein clearance.
Lonskaya I; Desforges NM; Hebron ML; Moussa CE
PLoS One; 2013; 8(12):e83914. PubMed ID: 24386307
[TBL] [Abstract][Full Text] [Related]
6. Novel Ubiquitin Specific Protease-13 Inhibitors Alleviate Neurodegenerative Pathology.
Liu X; Balaraman K; Lynch CC; Hebron M; Wolf C; Moussa C
Metabolites; 2021 Sep; 11(9):. PubMed ID: 34564439
[TBL] [Abstract][Full Text] [Related]
7. The interplay between parkin and alpha-synuclein; possible implications for the pathogenesis of Parkinson's disease.
Jęśko H; Lenkiewicz AM; Wilkaniec A; Adamczyk A
Acta Neurobiol Exp (Wars); 2019; 79(3):276-289. PubMed ID: 31587020
[TBL] [Abstract][Full Text] [Related]
8. The deubiquitinase USP15 antagonizes Parkin-mediated mitochondrial ubiquitination and mitophagy.
Cornelissen T; Haddad D; Wauters F; Van Humbeeck C; Mandemakers W; Koentjoro B; Sue C; Gevaert K; De Strooper B; Verstreken P; Vandenberghe W
Hum Mol Genet; 2014 Oct; 23(19):5227-42. PubMed ID: 24852371
[TBL] [Abstract][Full Text] [Related]
9. Altered α-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains.
Brudek T; Winge K; Rasmussen NB; Bahl JM; Tanassi J; Agander TK; Hyde TM; Pakkenberg B
J Neurochem; 2016 Jan; 136(1):172-85. PubMed ID: 26465922
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitination of alpha-synuclein by Siah-1 promotes alpha-synuclein aggregation and apoptotic cell death.
Lee JT; Wheeler TC; Li L; Chin LS
Hum Mol Genet; 2008 Mar; 17(6):906-17. PubMed ID: 18065497
[TBL] [Abstract][Full Text] [Related]
11. Regulatory Role of Ubiquitin Specific Protease-13 (USP13) in Misfolded Protein Clearance in Neurodegenerative Diseases.
Liu X; Moussa C
Neuroscience; 2021 Apr; 460():161-166. PubMed ID: 33577955
[TBL] [Abstract][Full Text] [Related]
12. Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation.
Xiong H; Wang D; Chen L; Choo YS; Ma H; Tang C; Xia K; Jiang W; Ronai Z; Zhuang X; Zhang Z
J Clin Invest; 2009 Mar; 119(3):650-60. PubMed ID: 19229105
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitin ligase Nedd4 promotes alpha-synuclein degradation by the endosomal-lysosomal pathway.
Tofaris GK; Kim HT; Hourez R; Jung JW; Kim KP; Goldberg AL
Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17004-9. PubMed ID: 21953697
[TBL] [Abstract][Full Text] [Related]
14. Interaction between Parkin and
Madsen DA; Schmidt SI; Blaabjerg M; Meyer M
Cells; 2021 Jan; 10(2):. PubMed ID: 33572534
[TBL] [Abstract][Full Text] [Related]
15. Parkin counteracts symptoms in a Drosophila model of Parkinson's disease.
Haywood AF; Staveley BE
BMC Neurosci; 2004 Apr; 5():14. PubMed ID: 15090075
[TBL] [Abstract][Full Text] [Related]
16. The ubiquitin ligase E6-AP promotes degradation of alpha-synuclein.
Mulherkar SA; Sharma J; Jana NR
J Neurochem; 2009 Sep; 110(6):1955-64. PubMed ID: 19645749
[TBL] [Abstract][Full Text] [Related]
17. The Role of NEDD4 E3 Ubiquitin-Protein Ligases in Parkinson's Disease.
Conway JA; Kinsman G; Kramer ER
Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328067
[TBL] [Abstract][Full Text] [Related]
18. Roflupram attenuates α-synuclein-induced cytotoxicity and promotes the mitochondrial translocation of Parkin in SH-SY5Y cells overexpressing A53T mutant α-synuclein.
Zhong J; Li M; Xu J; Dong W; Qin Y; Qiu S; Li X; Wang H
Toxicol Appl Pharmacol; 2022 Feb; 436():115859. PubMed ID: 34990728
[TBL] [Abstract][Full Text] [Related]
19. c-Abl phosphorylates α-synuclein and regulates its degradation: implication for α-synuclein clearance and contribution to the pathogenesis of Parkinson's disease.
Mahul-Mellier AL; Fauvet B; Gysbers A; Dikiy I; Oueslati A; Georgeon S; Lamontanara AJ; Bisquertt A; Eliezer D; Masliah E; Halliday G; Hantschel O; Lashuel HA
Hum Mol Genet; 2014 Jun; 23(11):2858-79. PubMed ID: 24412932
[TBL] [Abstract][Full Text] [Related]
20. Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation.
Lim KL; Chew KC; Tan JM; Wang C; Chung KK; Zhang Y; Tanaka Y; Smith W; Engelender S; Ross CA; Dawson VL; Dawson TM
J Neurosci; 2005 Feb; 25(8):2002-9. PubMed ID: 15728840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
